0001104659-20-135400.txt : 20201214 0001104659-20-135400.hdr.sgml : 20201214 20201214203318 ACCESSION NUMBER: 0001104659-20-135400 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201214 DATE AS OF CHANGE: 20201214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shah Rajeev M. CENTRAL INDEX KEY: 0001619841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38360 FILM NUMBER: 201387891 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solid Biosciences Inc. CENTRAL INDEX KEY: 0001707502 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 900943402 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 141 PORTLAND STREET, FIFTH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-337-4680 MAIL ADDRESS: STREET 1: 141 PORTLAND STREET, FIFTH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Solid Biosciences, LLC DATE OF NAME CHANGE: 20170524 4 1 tm2038490-1_form4.xml OWNERSHIP DOCUMENT X0306 4 2020-12-10 0 0001707502 Solid Biosciences Inc. SLDB 0001619841 Shah Rajeev M. C/O RA CAPITAL MANAGEMENT, L.P. 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 1 0 1 0 Common Stock 2020-12-10 4 A 0 4938282 3.70 A 8709882 I See footnote The securities reported on this Form 4 exclude 799,564 shares held in an account owned by a separately managed account (the "Account") that were reported on the previous Form 4 filed by Mr. Shah. RA Capital Management, L.P. (the "Adviser") is the investment adviser of the Account. The shares held by the Account have been excluded from the securities reported on this Form 4 pursuant to Rule 16a-1(a)(2)(ii)(C). The Adviser is the investment manager for the RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The filing of this Form 4 shall not be construed as an admission that Mr. Shah is or was for the purposes of Section 16(a), or otherwise, the beneficial owner of the reported securities, and he disclaims beneficial ownership of the reported securities except to the extent of any pecuniary interest. /s/ Rajeev Shah, individually 2020-12-14